• Beleave (CSE:BE) has partnered with Dutchman’s Gold to produce and distribute cannabis-infused honey products
  • The products will sell under the Sticky Icky and Dutchman’s Gold brands, for the Cannabis 2.0 Canadian market
  • Beleave and Dutchman’s Gold will both seek approval from their Board of Directors to complete the transaction
  • Beleave’s share price remains steady, and is currently trading at 2.5 cents per share

Cannabis company Beleave (CSE:BE) has partnered with honey company Dutchman’s Gold to make cannabis-infused honey products.

The products will be produced and distributed under the Sticky Icky and Dutchman’s Gold brands, for the Cannabis 2.0 Canadian market. 

Dutchman’s Gold is a Canadian producer of organic honey and maple syrup products, based in Ontario. The company began selling bottled honey from their front porch, and in local farmer’s markets, in 1981. Almost forty years later, their two Ontario facilities employ dozens of local community members, and provide numerous bee products globally.

Per the non-binding Letter of Intent, Dutchman’s Gold will provide all of the required honey ingredients for formulating the product. Beleave will manufacture, package, label, and ship the cannabis-infused products to approved provincial distributors. 

Dutchman’s Gold will use Beleave’s extracts, edibles, and topicals licence and distribution agreements to sell their manufactured edibles.

Beleave CEO, Kevin Keagan, welcomed the partnership. “The evolution of Dutchman’s Gold and Sticky Icky brand portfolios has been in the works for quite some time. Our team is looking forward to working with them to develop these new product formulations for evolving consumer preferences,” he said.

“It’s been great working with everyone at Shaxon Enterprises, who helped facilitate this partnership. They’ve been instrumental in bringing numerous opportunities to launch Cannabis 2.0 products for the Canadian market” Kevin added.

In the coming weeks, Beleave and Dutchman’s Gold will ask their respective Board of Directors for their approval, in order to complete the transaction. 

Beleave’s share price remains steady, and is currently trading at 2.5 cents per share at 2:15pm EST.

More From The Market Online

The Market Online’s Weekly Cannabis Report – April 19, 2024

Cannabis news this week: Canopy Growth shareholders overwhelmingly voted to approve a new class of exchangeable shares.

Buzz on the Bullboards: Challenges amid inflation and geopolitical tensions

Canadian and U.S. stock markets grapple with a host of challenges, from surging inflation data to escalating tensions in the Middle East.

Xebra Brands receives second CBD approval by Mexican authority

Xebra Brands (CSE:XBRA) announces it has received its second COFEPRIS approval for CBD product authorization in Mexico.
Canopy Growth - CEO, David Klein.

Canopy Growth shareholders approve Canopy USA asset strategy

After rearranging its capital structure, Canopy Growth (TSX:WEED) will be closer to establishing a U.S.-based multi-state operator.